Dear Sir,
It has been demonstrated that haemoglobin AI (HbA1) and glycosyl-albumin are valuable tools in monitoring diabetic control [1, 2] . Recently an increased non-enzymatic glycosylation of serum proteins (GSP) has been observed in diabetic subjects [3] . Therefore we have examined whether GSP is related to the degree of diabetic control, as assessed by HbAI, fasting blood glucose and urinary glucose excretion.
We have investigated blood glucose levels, HbAI and GSPin 17 control subjects (age 28-72 years, mean 52 years) and 44 diabetic patients (age 25-75 years, mean 48 years) following an overnight fast. In addition, the degree of medium-term diabetic control was evaluated on the basis of at least three fasting blood glucose values and 24h urinary glucose excretion performed at regular intervals during the 2-week period before the GSP and HbAI assays. Patients were divided into three groups according to their metabolic control: good, no 24 h glycosuria and fasting glycaemia < 7.2 mmol/1; fair, 24 h glycosuria < 555 mmol and glycaemia < 8.3 mmol/1; poor, 24 h glycosuria > 555 mmol and glycaemia > 8.3 mmol/1. Glycosylated serum protein was measured using a modification of the method described by Kennedy et al. [3] . HbAj was assayed by the micro-column technique (Bio-Rad, Richmond, USA).
Fasting blood glucose, HbA~ and GSP were found to be significantly higher in the diabetic than in the control subjects ( Table 1) . The degree of medium-term metabolic control was assessed as good in 15 cases, fair in 16 and poor in 13. All patients but one showed GSP values which were greater than two standard deviations above the mean found in the control subjects. In the healthy subjects, GSP levels correlated with the fasting blood glucose levels (r = 0.49, p < 0.05) and with HbA1 (r = 0.57, p < 0.05). In the diabetic subjects, GSP values were not correlated with fasting glycaemia (r = 0.13, p > 0.05), but a significant correlation was found with HbAI (r = 0.56, p < 0.001) and with the degree of mediumterm diabetic control evaluated by glycaemia and glycosuria levels observed during the previous 2 weeks (r = 0.69,p < 0.001).
These results suggest that GSP is not related to short-term fluctuations in blood glucose. Glycosylated serum protein values were better correlated with the degree of diabetic control during the 15 days before the study than with HbAI. It is likely that the GSP level depends on the blood glucose level found during the half-life of the serum proteins, which ranges from 2.5 to 23 days for different fractions. The finding that GSP may be high, even in patients judged to have good or fair metabolic control, could indicate that serum proteins may undergo significant glycosylation in response to blood glucose concentrations which are not particularly high. Alternatively, it could confirm the unreliability of assessing diabetic control by the usual criteria.
In conclusion we believe that GSP is a useful index of carbohydrate intolerance and provides a method for evaluating mediumterm metabolic control, thus providing a valid means of monitoring the efficacy of therapy.
Yours sincerely, G. Gragnoli, I. Tanganelli, A. M. Signorini, P. Tarli and C. Paoli
